Mayo Clinic and Bayesian Health Create AI Tool for Early Palliative Care Identification
Mayo Clinic and Bayesian Health announced in a press release that they have co-developed an artificial intelligence solution to identify hospitalized patients who may benefit from palliative care earlier in their stay. The system is designed to support timely consultations and reduce non-beneficial readmissions among patients with serious illness.
The AI tool, built on Bayesian Health's clinical intelligence platform, integrates directly into the electronic health record to provide clinicians with patient-specific insights within their workflow. It helps care teams recognize unmet palliative needs such as pain management or caregiver support and facilitates coordination with specialists.
In a randomized clinical trial at Mayo Clinic, use of the system was associated with a 44 percent increase in timely palliative care referrals, a 25 percent reduction in 60-day readmissions, and a 28 percent reduction in 90-day readmissions. The tool continuously learns from clinician feedback and local patient data to improve accuracy over time.
This collaboration, developed under Mayo Clinic's Practice Transformation Ventures framework, marks the first use of AI across the entire care process in a complex hospital setting at the institution.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice Operations Oct 15 Study Tracks 270 Million Clinical AI Queries on OpenEvidenceLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Blue Cross Analysis Links Hospital AI to $942 Million in Added Costs
AbbVie Partners With Valkai on AI Tools for Clinical Development
CIPRA.ai and Murata Explore AI Wearables for Chronic Care
PhyPal Relaunches Patient Engagement Platform With Conversational AI
AKASA Launches Autonomous AI Platform for Inpatient Coding
Daily AI Brief: the AI news that matters, in your inbox.